Stereotaxis, Inc.
STXS- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001289340
No open-market purchases or sales by Stereotaxis, Inc. insiders were filed in the last 90 days; 108 institutions reported holding it in 13F filings for Q2 2026, worth $74.1M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Stereotaxis, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 81 | 99 | +18 |
| Shares | 43.3M | 43.9M | +581.0K (+1.3%) |
| Value | $291.1M | $423.1M | +$132.1M (+45.4%) |
New holders (27)
Institutions that held Stereotaxis, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (9)
Institutions that held Stereotaxis, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Consonance Capital Management LP | 3,508,676 | $23.6M |
| Schonfeld Strategic Advisors LLC | 118,000 | $793.0K |
| California Public Employees Retirement System | 92,000 | $618.0K |
| Jane Street Group, LLC | 19,571 | $132.0K |
| Penn Capital Management Co Inc | 18,695 | $126.0K |
| Arkadios Wealth Advisors | 2,000 | $13.0K |
| Bank of Montreal | 1,224 | $9.00K |
| Simplex Trading, LLC | 750 | $5.00K |
| Brewin Dolphin Ltd | 500 | $3.36K |